No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

Author(s):

Edwina J. Wright, Birgit Grund, Kevin R. Robertson, Lucette Cysique, Bruce J. Brew, Gary L. Collins, Mollie Poehlman-Roediger, Michael J. Vjecha, Augusto César Penalva De Oliveira, Barbara Standridge, Cate Carey, Anchalee Avihingsanon, Eric Florence, Jens D. Lundgren, Alejandro Arenas-Pinto, Nicolas J. Mueller, Alan Winston, Moses S. Nsubuga, Luxshimi Lal, Richard W. Price

Details:

AIDS, Volume 32, Issue 8, 2018-05-15

Article Link: Click here

Affiliations:

• University College London
• Imperial College London
• University of Minnesota Twin Cities
• University of California, San Francisco
• The University of North Carolina at Chapel Hill
• Monash University
• UNSW Sydney
• Københavns Universitet
• Chulalongkorn University
• UniversitatsSpital Zurich
• School of Public Health
• St. Vincent's Hospital Sydney
• Prins Leopold Instituut voor Tropische Geneeskunde
• The Kirby Institute
• Burnet Institute
• Washington DC VA Medical Center
• Hospital Emilio Ribas
• Institute for Clinical Research
• People in Need Agency (PINA)